Ultimately, all these findings, through both genetic inhibition and overexpression of autophagy, indicated that Siglec-15-induced autophagy promoted the invasive and migratory ability of human osteosarcoma cells by targeting the EMT and Beclin-1/ATG14 pathway. The gene discussed is ATG14; the disease is osteosarcoma.